These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35808979)

  • 21. Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainability.
    Dylst P; Vulto A; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):33-42. PubMed ID: 25138241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine prices.
    Vogler S; Zimmermann N; Habl C; Mazag J
    Cost Eff Resour Alloc; 2013 Jul; 11(1):15. PubMed ID: 23826758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China.
    Wang X; Fang Y; Yang S; Jiang M; Yan K; Wu L; Lv B; Shen Q
    PLoS One; 2014; 9(3):e90365. PubMed ID: 24595099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy.
    Ezenduka CC; Ogbonna BO; Ekwunife OI; Okonta MJ; Esimone CO
    Malar J; 2014 Jun; 13():243. PubMed ID: 24961280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-efficacy modeling of catheter reuse for percutaneous transluminal coronary angioplasty.
    Mak KH; Eisenberg MJ; Eccleston DS; Brown KJ; Ellis SG; Topol EJ
    J Am Coll Cardiol; 1996 Jul; 28(1):106-11. PubMed ID: 8752801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [About direct and on behalf delivery of drugs.].
    De Rosa MM
    Recenti Prog Med; 2022 Dec; 113(12):705-714. PubMed ID: 36420846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicines as Common Commodities or Powerful Potions? What Makes Medicines Reusable in People's Eyes.
    Chauhan M; Alhamad H; McCrindle R; Hui TKL; Sherratt RS; Donyai P
    Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33924074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
    Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
    Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
    Orubu ESF; Robert FO; Samuel M; Megbule D
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reuse in sterile sites of single-use medical devices: how common is this in Australia?
    Collignon PJ; Graham E; Dreimanis DE
    Med J Aust; 1996 May; 164(9):533-6. PubMed ID: 8649288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The economic impact of reprocessing external fixation components.
    Horwitz DS; Schabel KL; Higgins TF
    J Bone Joint Surg Am; 2007 Oct; 89(10):2132-6. PubMed ID: 17908887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging.
    Andreu-Crespo À; Llibre JM; Cardona-Peitx G; Sala-Piñol F; Clotet B; Bonafont-Pujol X
    Drug Des Devel Ther; 2015; 9():4287-90. PubMed ID: 26273190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Validity of the Theory of Planned Behaviour for Understanding People's Beliefs and Intentions toward Reusing Medicines.
    Alhamad H; Donyai P
    Pharmacy (Basel); 2021 Mar; 9(1):. PubMed ID: 33803406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating essential medicines for treating childhood cancers: availability, price and affordability study in Ghana.
    Mensah KB; Mensah ABB; Bangalee V; Padayachee N; Oosthuizen F
    BMC Cancer; 2021 Jun; 21(1):683. PubMed ID: 34112117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlling medicine prices in Sudan: the challenge of the recently established medicines regulatory authority.
    Ali GK; Yahia Y
    East Mediterr Health J; 2012 Aug; 18(8):811-20. PubMed ID: 23057369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
    Morgan SG; Li W; Yau B; Persaud N
    CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability, pricing and affordability of selected medicines for noncommunicable diseases.
    Heidari E; Varmaghani M; Abdollahiasl A
    East Mediterr Health J; 2019 Oct; 25(7):473-480. PubMed ID: 31612979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies.
    Kakani P; Chernew M; Chandra A
    J Health Polit Policy Law; 2022 Dec; 47(6):629-648. PubMed ID: 35867538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability, prices and affordability of essential medicines in Haiti.
    Chahal HS; St Fort N; Bero L
    J Glob Health; 2013 Dec; 3(2):020405. PubMed ID: 24363923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.